Unbound MEDLINE

Aryl Hydrocarbon Receptor Interacting Protein Gene (AIP) Mutations are Rare in Patients with Hormone Secreting or Non-secreting Pituitary Adenomas. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association [Exp Clin Endocrinol Diabetes] Journal article

 
TitleAryl Hydrocarbon Receptor Interacting Protein Gene (AIP) Mutations are Rare in Patients with Hormone Secreting or Non-secreting Pituitary Adenomas.
Author(s)Buchbinder S, Bierhaus A, Zorn M, Nawroth PP, Humpert P, Schilling T 
Institution1University of Heidelberg, Department of Internal Medicine, Endocrinology, Metabolism and Clinical Chemistry Heidelberg, Germany.
SourceExp Clin Endocrinol Diabetes 2008 May 16.
AbstractOBJECTIVE: Recent data suggest that mutations in the aryl hydrocarbon receptor interacting protein gene (AIP) are associated with pituitary adenomas. AIP is considered to be a tumour suppressor gene.
METHODS: 110 Caucasian patients living in Germany with pituitary adenoma (55 hormone secreting, 55 non-functioning) were examined for AIP mutations.
RESULTS: Three patients (2.7%) harboured an AIP germline mutation. A heterozygous mutation, R16H (c.47G>A), was found in two patients and a heterozygous G>C change in the 3'UTR, 60 bp downstream of the termination codon, in one patient. All three patients suffered from non-functioning adenoma. Additionally, a silent polymorphism, D172D (c.516C>T), was found in 3 patients with non-functioning adenoma, in 2 patients with prolactinoma and in one patient with acromegaly.
CONCLUSIONS: AIP mutations are rare in sporadic pituitary adenomas in the German population and occur independently from a hormone secretion of the adenoma.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID18484068
  
Advertise on this site.